Global Veterinary Genetic Engineering Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 152
Published Date: 11 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Veterinary Genetic Engineering Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 578%.
The Global Info Research report includes an overview of the development of the Veterinary Genetic Engineering Vaccines industry chain, the market status of Poultry (Genetic Recombinant Vaccine, Recombinant Subunit Vaccines), Livestock (Genetic Recombinant Vaccine, Recombinant Subunit Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Veterinary Genetic Engineering Vaccines.
Regionally, the report analyzes the Veterinary Genetic Engineering Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Veterinary Genetic Engineering Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Veterinary Genetic Engineering Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Veterinary Genetic Engineering Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Genetic Recombinant Vaccine, Recombinant Subunit Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Veterinary Genetic Engineering Vaccines market.
Regional Analysis: The report involves examining the Veterinary Genetic Engineering Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Veterinary Genetic Engineering Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Veterinary Genetic Engineering Vaccines:
Company Analysis: Report covers individual Veterinary Genetic Engineering Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Veterinary Genetic Engineering Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Poultry, Livestock).
Technology Analysis: Report covers specific technologies relevant to Veterinary Genetic Engineering Vaccines. It assesses the current state, advancements, and potential future developments in Veterinary Genetic Engineering Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Veterinary Genetic Engineering Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Veterinary Genetic Engineering Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine
Market segment by Application
Poultry
Livestock
Other
Major players covered
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Santé Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Veterinary Genetic Engineering Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Genetic Engineering Vaccines, with price, sales, revenue and global market share of Veterinary Genetic Engineering Vaccines from 2019 to 2024.
Chapter 3, the Veterinary Genetic Engineering Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Genetic Engineering Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Veterinary Genetic Engineering Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Genetic Engineering Vaccines.
Chapter 14 and 15, to describe Veterinary Genetic Engineering Vaccines sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Veterinary Genetic Engineering Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Veterinary Genetic Engineering Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Genetic Recombinant Vaccine
1.3.3 Recombinant Subunit Vaccines
1.3.4 Genetic Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Veterinary Genetic Engineering Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Poultry
1.4.3 Livestock
1.4.4 Other
1.5 Global Veterinary Genetic Engineering Vaccines Market Size & Forecast
1.5.1 Global Veterinary Genetic Engineering Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Veterinary Genetic Engineering Vaccines Sales Quantity (2019-2030)
1.5.3 Global Veterinary Genetic Engineering Vaccines Average Price (2019-2030)
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Veterinary Genetic Engineering Vaccines Product and Services
2.1.4 Merck Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Veterinary Genetic Engineering Vaccines Product and Services
2.2.4 GSK Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Veterinary Genetic Engineering Vaccines Product and Services
2.3.4 Sanofi Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments/Updates
2.4 Zoties
2.4.1 Zoties Details
2.4.2 Zoties Major Business
2.4.3 Zoties Veterinary Genetic Engineering Vaccines Product and Services
2.4.4 Zoties Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Zoties Recent Developments/Updates
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco Veterinary Genetic Engineering Vaccines Product and Services
2.5.4 Elanco Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Elanco Recent Developments/Updates
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product and Services
2.6.4 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Boehringer Ingelheim Recent Developments/Updates
2.7 Indian Immunologicals
2.7.1 Indian Immunologicals Details
2.7.2 Indian Immunologicals Major Business
2.7.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Product and Services
2.7.4 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Indian Immunologicals Recent Developments/Updates
2.8 China Animal Husbandry Industry Co.,Ltd.
2.8.1 China Animal Husbandry Industry Co.,Ltd. Details
2.8.2 China Animal Husbandry Industry Co.,Ltd. Major Business
2.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product and Services
2.8.4 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
2.9 Yebio Bioengineering Co., Ltd Of Qingdao
2.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Details
2.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Major Business
2.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product and Services
2.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
2.10 Jinyu Bio-technology Co.,ltd.
2.10.1 Jinyu Bio-technology Co.,ltd. Details
2.10.2 Jinyu Bio-technology Co.,ltd. Major Business
2.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product and Services
2.10.4 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
2.11 HVRI
2.11.1 HVRI Details
2.11.2 HVRI Major Business
2.11.3 HVRI Veterinary Genetic Engineering Vaccines Product and Services
2.11.4 HVRI Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 HVRI Recent Developments/Updates
2.12 Ringpu Biology
2.12.1 Ringpu Biology Details
2.12.2 Ringpu Biology Major Business
2.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Product and Services
2.12.4 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Ringpu Biology Recent Developments/Updates
2.13 Kyoto Biken Laboratories
2.13.1 Kyoto Biken Laboratories Details
2.13.2 Kyoto Biken Laboratories Major Business
2.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product and Services
2.13.4 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Kyoto Biken Laboratories Recent Developments/Updates
2.14 FATRO
2.14.1 FATRO Details
2.14.2 FATRO Major Business
2.14.3 FATRO Veterinary Genetic Engineering Vaccines Product and Services
2.14.4 FATRO Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 FATRO Recent Developments/Updates
2.15 Ceva Santé Animale
2.15.1 Ceva Santé Animale Details
2.15.2 Ceva Santé Animale Major Business
2.15.3 Ceva Santé Animale Veterinary Genetic Engineering Vaccines Product and Services
2.15.4 Ceva Santé Animale Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ceva Santé Animale Recent Developments/Updates
2.16 Pulike Biological Engineering,Inc.
2.16.1 Pulike Biological Engineering,Inc. Details
2.16.2 Pulike Biological Engineering,Inc. Major Business
2.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product and Services
2.16.4 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Pulike Biological Engineering,Inc. Recent Developments/Updates
2.17 Wuhan Hvsen Biotechnology CO.,LTD
2.17.1 Wuhan Hvsen Biotechnology CO.,LTD Details
2.17.2 Wuhan Hvsen Biotechnology CO.,LTD Major Business
2.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product and Services
2.17.4 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
2.18 Jinhe Biotechnology Co., Ltd.
2.18.1 Jinhe Biotechnology Co., Ltd. Details
2.18.2 Jinhe Biotechnology Co., Ltd. Major Business
2.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product and Services
2.18.4 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
2.19 Shanghai Shen Lian Biomedical Corporation
2.19.1 Shanghai Shen Lian Biomedical Corporation Details
2.19.2 Shanghai Shen Lian Biomedical Corporation Major Business
2.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product and Services
2.19.4 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
2.20 Qingdao Vland Biotech INC.
2.20.1 Qingdao Vland Biotech INC. Details
2.20.2 Qingdao Vland Biotech INC. Major Business
2.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product and Services
2.20.4 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Qingdao Vland Biotech INC. Recent Developments/Updates
3.1 Global Veterinary Genetic Engineering Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Veterinary Genetic Engineering Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Veterinary Genetic Engineering Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Veterinary Genetic Engineering Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Veterinary Genetic Engineering Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Veterinary Genetic Engineering Vaccines Manufacturer Market Share in 2023
3.5 Veterinary Genetic Engineering Vaccines Market: Overall Company Footprint Analysis
3.5.1 Veterinary Genetic Engineering Vaccines Market: Region Footprint
3.5.2 Veterinary Genetic Engineering Vaccines Market: Company Product Type Footprint
3.5.3 Veterinary Genetic Engineering Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Veterinary Genetic Engineering Vaccines Market Size by Region
4.1.1 Global Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Veterinary Genetic Engineering Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Veterinary Genetic Engineering Vaccines Average Price by Region (2019-2030)
4.2 North America Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030)
4.3 Europe Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030)
4.5 South America Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030)
5.1 Global Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Veterinary Genetic Engineering Vaccines Consumption Value by Type (2019-2030)
5.3 Global Veterinary Genetic Engineering Vaccines Average Price by Type (2019-2030)
6.1 Global Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Veterinary Genetic Engineering Vaccines Consumption Value by Application (2019-2030)
6.3 Global Veterinary Genetic Engineering Vaccines Average Price by Application (2019-2030)
7.1 North America Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Veterinary Genetic Engineering Vaccines Market Size by Country
7.3.1 North America Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Veterinary Genetic Engineering Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Veterinary Genetic Engineering Vaccines Market Size by Country
8.3.1 Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Veterinary Genetic Engineering Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Veterinary Genetic Engineering Vaccines Market Size by Region
9.3.1 Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Veterinary Genetic Engineering Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Veterinary Genetic Engineering Vaccines Market Size by Country
10.3.1 South America Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Veterinary Genetic Engineering Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Veterinary Genetic Engineering Vaccines Market Size by Country
11.3.1 Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Veterinary Genetic Engineering Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Veterinary Genetic Engineering Vaccines Market Drivers
12.2 Veterinary Genetic Engineering Vaccines Market Restraints
12.3 Veterinary Genetic Engineering Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Veterinary Genetic Engineering Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Veterinary Genetic Engineering Vaccines
13.3 Veterinary Genetic Engineering Vaccines Production Process
13.4 Veterinary Genetic Engineering Vaccines Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Veterinary Genetic Engineering Vaccines Typical Distributors
14.3 Veterinary Genetic Engineering Vaccines Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Veterinary Genetic Engineering Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Veterinary Genetic Engineering Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Veterinary Genetic Engineering Vaccines Product and Services
Table 6. Merck Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Veterinary Genetic Engineering Vaccines Product and Services
Table 11. GSK Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Veterinary Genetic Engineering Vaccines Product and Services
Table 16. Sanofi Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Sanofi Recent Developments/Updates
Table 18. Zoties Basic Information, Manufacturing Base and Competitors
Table 19. Zoties Major Business
Table 20. Zoties Veterinary Genetic Engineering Vaccines Product and Services
Table 21. Zoties Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Zoties Recent Developments/Updates
Table 23. Elanco Basic Information, Manufacturing Base and Competitors
Table 24. Elanco Major Business
Table 25. Elanco Veterinary Genetic Engineering Vaccines Product and Services
Table 26. Elanco Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Elanco Recent Developments/Updates
Table 28. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 29. Boehringer Ingelheim Major Business
Table 30. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product and Services
Table 31. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Boehringer Ingelheim Recent Developments/Updates
Table 33. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 34. Indian Immunologicals Major Business
Table 35. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product and Services
Table 36. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Indian Immunologicals Recent Developments/Updates
Table 38. China Animal Husbandry Industry Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. China Animal Husbandry Industry Co.,Ltd. Major Business
Table 40. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product and Services
Table 41. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
Table 43. Yebio Bioengineering Co., Ltd Of Qingdao Basic Information, Manufacturing Base and Competitors
Table 44. Yebio Bioengineering Co., Ltd Of Qingdao Major Business
Table 45. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product and Services
Table 46. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
Table 48. Jinyu Bio-technology Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Jinyu Bio-technology Co.,ltd. Major Business
Table 50. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product and Services
Table 51. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
Table 53. HVRI Basic Information, Manufacturing Base and Competitors
Table 54. HVRI Major Business
Table 55. HVRI Veterinary Genetic Engineering Vaccines Product and Services
Table 56. HVRI Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. HVRI Recent Developments/Updates
Table 58. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 59. Ringpu Biology Major Business
Table 60. Ringpu Biology Veterinary Genetic Engineering Vaccines Product and Services
Table 61. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Ringpu Biology Recent Developments/Updates
Table 63. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Kyoto Biken Laboratories Major Business
Table 65. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product and Services
Table 66. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Kyoto Biken Laboratories Recent Developments/Updates
Table 68. FATRO Basic Information, Manufacturing Base and Competitors
Table 69. FATRO Major Business
Table 70. FATRO Veterinary Genetic Engineering Vaccines Product and Services
Table 71. FATRO Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. FATRO Recent Developments/Updates
Table 73. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 74. Ceva Santé Animale Major Business
Table 75. Ceva Santé Animale Veterinary Genetic Engineering Vaccines Product and Services
Table 76. Ceva Santé Animale Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Ceva Santé Animale Recent Developments/Updates
Table 78. Pulike Biological Engineering,Inc. Basic Information, Manufacturing Base and Competitors
Table 79. Pulike Biological Engineering,Inc. Major Business
Table 80. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product and Services
Table 81. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Pulike Biological Engineering,Inc. Recent Developments/Updates
Table 83. Wuhan Hvsen Biotechnology CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 84. Wuhan Hvsen Biotechnology CO.,LTD Major Business
Table 85. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product and Services
Table 86. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
Table 88. Jinhe Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 89. Jinhe Biotechnology Co., Ltd. Major Business
Table 90. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product and Services
Table 91. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
Table 93. Shanghai Shen Lian Biomedical Corporation Basic Information, Manufacturing Base and Competitors
Table 94. Shanghai Shen Lian Biomedical Corporation Major Business
Table 95. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product and Services
Table 96. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
Table 98. Qingdao Vland Biotech INC. Basic Information, Manufacturing Base and Competitors
Table 99. Qingdao Vland Biotech INC. Major Business
Table 100. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product and Services
Table 101. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Qingdao Vland Biotech INC. Recent Developments/Updates
Table 103. Global Veterinary Genetic Engineering Vaccines Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 104. Global Veterinary Genetic Engineering Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Veterinary Genetic Engineering Vaccines Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 106. Market Position of Manufacturers in Veterinary Genetic Engineering Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Veterinary Genetic Engineering Vaccines Production Site of Key Manufacturer
Table 108. Veterinary Genetic Engineering Vaccines Market: Company Product Type Footprint
Table 109. Veterinary Genetic Engineering Vaccines Market: Company Product Application Footprint
Table 110. Veterinary Genetic Engineering Vaccines New Market Entrants and Barriers to Market Entry
Table 111. Veterinary Genetic Engineering Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 113. Global Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 114. Global Veterinary Genetic Engineering Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Veterinary Genetic Engineering Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Veterinary Genetic Engineering Vaccines Average Price by Region (2019-2024) & (US$/Unit)
Table 117. Global Veterinary Genetic Engineering Vaccines Average Price by Region (2025-2030) & (US$/Unit)
Table 118. Global Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Global Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Global Veterinary Genetic Engineering Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Veterinary Genetic Engineering Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Veterinary Genetic Engineering Vaccines Average Price by Type (2019-2024) & (US$/Unit)
Table 123. Global Veterinary Genetic Engineering Vaccines Average Price by Type (2025-2030) & (US$/Unit)
Table 124. Global Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Global Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Global Veterinary Genetic Engineering Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Veterinary Genetic Engineering Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Veterinary Genetic Engineering Vaccines Average Price by Application (2019-2024) & (US$/Unit)
Table 129. Global Veterinary Genetic Engineering Vaccines Average Price by Application (2025-2030) & (US$/Unit)
Table 130. North America Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 131. North America Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 132. North America Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 133. North America Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 134. North America Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 135. North America Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 136. North America Veterinary Genetic Engineering Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Veterinary Genetic Engineering Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 141. Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 142. Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 143. Europe Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 144. Europe Veterinary Genetic Engineering Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Veterinary Genetic Engineering Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 147. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 148. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 149. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 150. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 151. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 152. Asia-Pacific Veterinary Genetic Engineering Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Veterinary Genetic Engineering Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 155. South America Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 156. South America Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 157. South America Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 158. South America Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2019-2024) & (K Units)
Table 159. South America Veterinary Genetic Engineering Vaccines Sales Quantity by Country (2025-2030) & (K Units)
Table 160. South America Veterinary Genetic Engineering Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Veterinary Genetic Engineering Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2019-2024) & (K Units)
Table 163. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Type (2025-2030) & (K Units)
Table 164. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2019-2024) & (K Units)
Table 165. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Application (2025-2030) & (K Units)
Table 166. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2019-2024) & (K Units)
Table 167. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity by Region (2025-2030) & (K Units)
Table 168. Middle East & Africa Veterinary Genetic Engineering Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Veterinary Genetic Engineering Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Veterinary Genetic Engineering Vaccines Raw Material
Table 171. Key Manufacturers of Veterinary Genetic Engineering Vaccines Raw Materials
Table 172. Veterinary Genetic Engineering Vaccines Typical Distributors
Table 173. Veterinary Genetic Engineering Vaccines Typical Customers
List of Figures
Figure 1. Veterinary Genetic Engineering Vaccines Picture
Figure 2. Global Veterinary Genetic Engineering Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Genetic Recombinant Vaccine Examples
Figure 5. Recombinant Subunit Vaccines Examples
Figure 6. Genetic Vaccine Examples
Figure 7. Global Veterinary Genetic Engineering Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Application in 2023
Figure 9. Poultry Examples
Figure 10. Livestock Examples
Figure 11. Other Examples
Figure 12. Global Veterinary Genetic Engineering Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Veterinary Genetic Engineering Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Veterinary Genetic Engineering Vaccines Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Veterinary Genetic Engineering Vaccines Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Veterinary Genetic Engineering Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Veterinary Genetic Engineering Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Veterinary Genetic Engineering Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Veterinary Genetic Engineering Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Veterinary Genetic Engineering Vaccines Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Veterinary Genetic Engineering Vaccines Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 54. China Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Veterinary Genetic Engineering Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Veterinary Genetic Engineering Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Veterinary Genetic Engineering Vaccines Market Drivers
Figure 75. Veterinary Genetic Engineering Vaccines Market Restraints
Figure 76. Veterinary Genetic Engineering Vaccines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Veterinary Genetic Engineering Vaccines in 2023
Figure 79. Manufacturing Process Analysis of Veterinary Genetic Engineering Vaccines
Figure 80. Veterinary Genetic Engineering Vaccines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Merck GSK Sanofi Zoties Elanco Boehringer Ingelheim Indian Immunologicals China Animal Husbandry Industry Co.,Ltd. Yebio Bioengineering Co., Ltd Of Qingdao Jinyu Bio-technology Co.,ltd. HVRI Ringpu Biology Kyoto Biken Laboratories FATRO Ceva Santé Animale Pulike Biological Engineering,Inc. Wuhan Hvsen Biotechnology CO.,LTD Jinhe Biotechnology Co., Ltd. Shanghai Shen Lian Biomedical Corporation Qingdao Vland Biotech INC.
Related Reports
09 Mar 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
